相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sublingual Administration of an Adenovirus Serotype 5 (Ad5)-Based Vaccine Confirms Toll-Like Receptor Agonist Activity in the Oral Cavity and Elicits Improved Mucosal and Systemic Cell-Mediated Responses against HIV Antigens despite Preexisting Ad5 Immunity
Daniel M. Appledorn et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Simultaneous Approach Using Systemic, Mucosal and Transcutaneous Routes of Immunization For Development of Protective HIV-1 Vaccines
I. M. Belyakov et al.
CURRENT MEDICINAL CHEMISTRY (2011)
HIV vaccine efficacy trial: Glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity
Leia Wren et al.
HUMAN VACCINES (2011)
Durable Mucosal Simian Immunodeficiency Virus-Specific Effector Memory T Lymphocyte Responses Elicited by Recombinant Adenovirus Vectors in Rhesus Monkeys
Hualin Li et al.
JOURNAL OF VIROLOGY (2011)
TRIM5α Does Not Affect Simian Immunodeficiency Virus SIVmac251 Replication in Vaccinated or Unvaccinated Indian Rhesus Macaques following Intrarectal Challenge Exposure
Claudio Fenizia et al.
JOURNAL OF VIROLOGY (2011)
Adenovirus type 5 induces vitamin A-metabolizing enzymes in dendritic cells and enhances priming of gut-homing CD8 T cells
S. Ganguly et al.
MUCOSAL IMMUNOLOGY (2011)
Mucosal memory CD8+ T cells are selected in the periphery by an MHC class I molecule
Yujun Huang et al.
NATURE IMMUNOLOGY (2011)
Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia
Egidio Brocca-Cofano et al.
VACCINE (2011)
Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques
Marta L. Marthas et al.
VACCINE (2011)
Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge
L. Jean Patterson et al.
VIROLOGY (2011)
Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Δnef and challenged with pathogenic SIVmac251
Doris Freissmuth et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2010)
Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses
Eun Mi Lee et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Route of Adenovirus-Based HIV-1 Vaccine Delivery Impacts the Phenotype and Trafficking of Vaccine-Elicited CD8+ T Lymphocytes
David R. Kaufman et al.
JOURNAL OF VIROLOGY (2010)
Multiple Vaccine-Elicited Nonneutralizing Antienvelope Antibody Activities Contribute to Protective Efficacy by Reducing both Acute and Chronic Viremia following Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques
Peng Xiao et al.
JOURNAL OF VIROLOGY (2010)
Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys
Jinyan Liu et al.
JOURNAL OF VIROLOGY (2010)
Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract
Catherine Hervouet et al.
VACCINE (2010)
TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants
Sarah C. Higgins et al.
Current Infectious Disease Reports (2010)
Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239
Panagiotis Vagenas et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1
Brandon F. Keele et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge of Rhesus Macaques
Rachmat Hidajat et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development
L. Jean Patterson et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Failure of the Merck HIV vaccine: an uncertain step forward
Merlin L. Robb
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Sublingual immunotherapy
Anthony J. Frew
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sublingual vaccination with influenza virus protects mice against lethal viral infection
Joo-Hye Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection
Brandon F. Keele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge
Willy M. J. M. Bogers et al.
VIROLOGY (2008)
Sublingual immunization induces broad-based systemic and mucosal immune responses in mice
Nicolas Cuburu et al.
VACCINE (2007)
Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIVmac251
Qifeng Zhou et al.
VACCINE (2007)
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
John T. Loffredo et al.
JOURNAL OF VIROLOGY (2007)
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques
Thorsten Demberg et al.
JOURNAL OF VIROLOGY (2007)
A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum
Christiane Stahl-Hennig et al.
FRONTIERS IN BIOSCIENCE (2007)
Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge:: Role of SIV-specific CD8+ T cell responses
Nina V. Malkevitch et al.
VIROLOGY (2006)
Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells
Donald N. Forthal et al.
JOURNAL OF VIROLOGY (2006)
A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity
VR Gómez-Román et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
JJ Mattapallil et al.
NATURE (2005)
Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following Ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE
J Pinczewski et al.
VIRAL IMMUNOLOGY (2005)
Protection against mucosal simian immunodeficiency virus SIVmac251 challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting
LJ Patterson et al.
JOURNAL OF VIROLOGY (2004)
Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function
BE Palmer et al.
JOURNAL OF IMMUNOLOGY (2004)
Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates
AB McDermott et al.
JOURNAL OF VIROLOGY (2004)
Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection
LJ Picker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
M Pope et al.
NATURE MEDICINE (2003)
Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication
BR Mothé et al.
JOURNAL OF VIROLOGY (2003)
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency
R Pal et al.
JOURNAL OF VIROLOGY (2002)
Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology
JW Romano et al.
JOURNAL OF VIROLOGICAL METHODS (2000)